What's new

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 33, Status: Authorised

Jun 17, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 33, Status: Authorised
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 33, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, ...

Next Article

Human medicines European public assessment report (EPAR): TachoSil, human fibrin...

Related Posts

Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation: 05/11/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Paediatric Committee (PDCO): 17-20 June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 17 June 2025 to 20 June 2025

Paediatric Committee (PDCO): 17-20 June 2025, Online, E...

Jun 17, 2025  0